NCT07898631Not yet recruiting
Reducing Stigma - A Treatment for Early Psychosis to Prevent Suicide
Source: ClinicalTrials.gov · Last updated 29 Oct 2026
Brief summary (registry, in English)
A mental health program, called RESTEPS, will be developed for patients with early psychosis being treated in outpatient mental health centers, focusing on reducing suicide risk by targeting mental health stigma and social support. Youth (n = 35) with psychosis and current/past suicidal thoughts or behaviors will be recruited from community mental health centers to complete an initial open trial examining the feasibility and acceptability of RESTEPS, an 8-session intervention. Participants will be assessed at baseline, mid-intervention, post-intervention, and at a 6-month follow-up.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 35 (estimated)
- First submitted
- 20 Oct 2026
- Start date
- 1 Dec 2026
- Primary completion date
- Jun 2028
- Lead sponsor
- Butler Hospital
- Diseases
- Schizophrenia
- NCT number
- NCT07898631
What you commit to
- Study type: Interventional
- Planned participants: 35
- From 1 Dec 2026 to the primary completion date, Jun 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Psychotic symptoms due solely to substance intoxication or withdrawal (otherwise, comorbid substance use disorders will be allowed) or a known medical condition
Other
- Severe current psychotic symptoms preventing the participant from providing informed consent/assent and/or being able to engage in the study procedures
- Involuntary hospital at the time of consent
Who the study is looking for
- 15-25 years of age
- Schizophrenia-spectrum disorder diagnosis (e.g., schizophreniform, schizoaffective disorder, schizophrenia, delusional disorder) or mood disorder with psychotic features (e.g., major depressive disorder with psychotic features, bipolar disorder with psychotic features) confirmed via Structured Clinical Interview for the DSM-5
- Positive psychotic symptom duration of \< 2 years OR currently receiving treatment in an early psychosis or first-episode psychosis clinic.
- Suicide risk defined as any lifetime suicide attempt or suicidal ideation (yes to Questions 1, 2, 3, 4, or 5 on the Columbia Suicide Severity Rating Scale or C-SSRS)
- For participants younger than 18 only, parent/guardian significant other willing to participate in the study
- Ability to speak and read English sufficiently to complete study procedures.
Age in the registry: 15 years to 25 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Butler Hospital Coordinator of this site? Confirm its status | Providence | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.